Pre-Indictment Posture in Healthcare Fraud Investigations

Pre-Indictment Posture in Healthcare Fraud Investigations at a Glance

Pre-indictment posture in healthcare fraud investigations refers to the stage before formal criminal charges are filed, during which individuals and entities under scrutiny may face significant legal exposure, particularly under the Anti-Kickback Statute (AKS) and related laws. This phase is critical for understanding potential liabilities, including both criminal and civil consequences, and often involves complex interplay between federal and state enforcement actions.

The Legal Framework

The Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), criminalizes the knowing and willful offer, payment, solicitation, or receipt of remuneration to induce or reward referrals of items or services payable by federal health care programs. Violations can result in fines of up to $100,000 or imprisonment of up to 10 years, or both. This statute serves as a cornerstone of federal enforcement in healthcare fraud investigations.

Under the False Claims Act (31 U.S.C. §§ 3729–3733), a qui tam relator may receive a share of the proceeds from a settlement or judgment. The relator’s share depends on whether the government intervenes in the case: 15–25% if the government proceeds with the action, 25–30% if the government declines, and no more than 10% if the action is based primarily on public disclosures. This provision incentivizes private citizens to report fraud, which can complicate the pre-indictment posture by introducing parallel civil liability.

The general statute of limitations for non-capital federal offenses, including AKS violations, is governed by 18 U.S.C. § 3282, which provides a five-year limitations period. This time frame is crucial for determining the scope of potential criminal exposure and may influence the timing of investigative actions and plea negotiations.

Enforcement and Cases

Healthcare fraud investigations often involve both criminal and civil enforcement mechanisms. Parallel False Claims Act exposure is the norm, as claims tainted by an AKS violation are considered false under 42 U.S.C. § 1320a-7b(g). This dual exposure increases the legal risks for individuals and entities involved in potentially fraudulent referral arrangements.

The Federal Overlay

The federal Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), makes it a felony to knowingly and willfully offer, pay, solicit, or receive remuneration to induce or reward referrals of items or services payable by a federal health care program. The Stark Law, 42 U.S.C. § 1395nn, separately prohibits physician self-referrals for designated health services payable by Medicare or Medicaid, on strict-liability terms. Both regimes carry safe harbors and exceptions published at 42 C.F.R. § 1001.952. State referral and fee-splitting statutes operate alongside these federal prohibitions and can apply even where no federal program payment is involved.

Reading the Research Desk

For further exploration of related topics, see our practice areas, explanation of the AKS, safe harbors analysis, AKS and Stark Law overlap, recent decisions, and FAQ sections.